AFP Clinical Answers

PID Treatment, Low Back Pain, Opioids, Plasma Injections, Sphygmomanometry

 

Am Fam Physician. 2020 Oct 1;102(7):398.

How should pelvic inflammatory disease be treated?

Empiric antibiotic treatment should be offered at the time of presentation to patients with pelvic inflammatory disease (PID) symptoms. Women with mild to moderate PID may be treated in an outpatient setting without increased risk of sequelae. Patient-delivered or expedited partner therapy for sexually transmitted infections should be offered where legal to decrease rates of reinfection.

https://www.aafp.org/afp/2019/0915/p357.html

Can history findings help rule out serious conditions related to low back pain?

Red flags can help rule out serious underlying etiologies of low back pain. The red flags for serious causes of low back pain include progressive weakness, saddle anesthesia, urinary retention, age older than 50 years, osteoporosis, trauma, infection, immunocompromise, intravenous drug use, night pain, oral steroid use, fever, history of malignancy, progressive pain, night pain, and unintended weight loss.

https://www.aafp.org/afp/2019/1201/p697.html

How should opioid use disorder be treated?

Patients with opioid use disorder should be offered pharmacotherapeutic maintenance treatment. Pharmacotherapy for opioid use disorder should be continued for as long as it helps the patient; patients should not be required to discontinue according to preset timelines. Participation in behavior therapies may be helpful for some patients with opioid use disorder, but studies are equivocal; it should not be a prerequisite for buprenorphine treatment. To prevent overdose, naloxone should be prescribed to all patients with opioid use disorder or high-risk prescription opioid use or who use any illicit drugs.

https://www.aafp.org/afp/2019/1001/p416.html

Are platelet-rich plasma injections beneficial in the nonoperative treatment of rotator cuff disease in adults?

A systematic review of five studies found no evidence that supports any additional benefit of platelet-rich plasma injections compared with various control interventions, in

 

 

Copyright © 2020 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP


Editor's Collections


More in Pubmed

MOST RECENT ISSUE


Nov 15, 2020

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article